Researchers identify new stem cell population important in the growth of colon cancer

June 16, 2015, Lawson Health Research Institute

Researchers at Lawson Health Research Institute have identified a new stem cell population in the colon linked to cancer growth. The findings, which were recently published in the prominent journal Cell Stem Cell, will significantly change the way we study and treat colon cancer.

Colon cancer is the second leading cause of in Canada. It is estimated that in 2015 that 25,100 Canadians will be diagnosed with colon cancer representing 13 percent of all new cancer cases.

Dr. Samuel Asfaha, a clinician-scientist at Lawson and an assistant professor of at the Schulich School of Medicine & Dentistry, Western University, and his colleagues at Columbia University (New York), have identified a previously unknown, long-lived radiation-resistant stem cell population in the colon. Most importantly, they also found that these stem cells can give rise to colonic tumors and sustain their growth. Tissue stem cells are unique cells essential for normal tissue maintenance and regeneration. Their unique characteristic of longevity, however, makes them the most likely cell of origin for cancer. In this study, the researchers sought to identify whether more than one tissue stem cell population exists within the colon which could be a source of colon cancer.

According to Asfaha, the identification of the cellular origin of cancer, specifically , is critical to the understanding of how cancer arises, as well as for the identification of new targets for drug therapy.

"The identification of more than one stem cell pool in the colon has proven challenging," stresse Asfaha. "These findings are exciting as we have identified an important new target for cancer therapy. It is also proof that more than one stem cell can give rise to and sustain tumors, telling us that our cancer therapy needs to target more than one stem cell pool."

Until now, the only stem cell population linked to was radiation sensitive, leading physicians to believe that radiation therapy was effective. "With this new information, we now know this is not always true and we must find new forms of therapy to target the disease," says Asfaha.

Explore further: Potential new colorectal cancer treatment target identified

More information: The study, "Krt19+/Lgr5- cells are radioresistant cancer-initiating stem cells in the colon and intestine' is published in the June 4 issue of Cell Stem Cell.

Related Stories

Potential new colorectal cancer treatment target identified

October 7, 2012
(HealthDay)—The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research ...

Team discovers novel mechanism controlling lung cancer stem cell growth

April 7, 2015
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many scientists ...

Colon cancer researchers target stem cells, discover viable new therapeutic path

December 1, 2013
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, ...

New study sheds light on cancer stem cell regulation

February 6, 2015
Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have discovered a precise stem cell signaling process that can lead to intestinal tumors if disrupted. The findings add to our understanding of how ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.